OSM CAR-T is a newly engineered immune-cell therapy designed to specifically target and destroy osteosarcoma, the most common form of bone cancer affecting children and young adults.
#Oncology #Immunology #CellBiology #cancer #sflorg
https://www.sflorg.com/2026/03/ongy03172601.html
Researchers develop promising new therapy for most common form of bone cancer in children and young adults

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children